Voisin Consulting Life Sciences glossary icon
Glossary

Comparability Protocol

Loading..
Click a letter to view all its definitions

A comprehensive, prospectively written plan for assessing the effect of a proposed CMC post-approval change on the identity, strength, quality, purity, and potency of a drug product or biological product.

 

Other glossary definitions

A

Appropriately Reduce (risk)

The reduction of risk to an acceptable level as determined by the manufacturer and regulatory…

View definition
P

Pseudonymization

Process that allows to switch the original data set (for example data subject’s e-mail or…

View definition
Voisin Consulting Life Sciences
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.